Orient EuroPharma Co., Ltd. (TPEX:4120)
Taiwan · Delayed Price · Currency is TWD 44.60
+0.25 (0.56%)
May 29, 2026, 1:30 PM CST
Orient EuroPharma Market Cap
Orient EuroPharma has a market cap or net worth of 3.87 billion as of May 29, 2026. Its market cap has decreased by -3.04% in one year.
Market Cap
3.87B
Enterprise Value
6.18B
Revenue
4.59B
Ranking
n/a
PE Ratio
n/a
Stock Price
44.60
Market Cap Chart
Since November 3, 2004, Orient EuroPharma's market cap has increased from 700.81M to 3.87B, an increase of 452.06%. That is a compound annual growth rate of 8.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 3.87B | -0.45% |
| Dec 31, 2025 | 3.89B | -7.05% |
| Dec 31, 2024 | 4.18B | 23.91% |
| Dec 29, 2023 | 3.37B | 7.46% |
| Dec 30, 2022 | 3.14B | -0.41% |
| Dec 30, 2021 | 3.15B | -24.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LIWANLI Innovation | 5.45B |
| Orient Pharma | 5.25B |
| SCI Pharmtech | 4.86B |
| Easywell Biomedicals | 4.21B |
| Yoda Pharmaceuticals | 3.45B |
| Allied Biotech | 3.25B |
| Tien Liang BioTech | 3.01B |
| Merdury Biopharmaceutical | 2.91B |